GlaxoSmithKline (GSK) Makes $129.38M Investment in Theravance (THRX)
Tweet Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) announced that they ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


